ArticleAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists2025

An evaluation of vilobelimab (anti-C5a) as a cost-effective option to treat severely ill mechanically ventilated patients with COVID-19.

Daniel C Malone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.